IL-12 enhancement of immune responses to T-independent antigens
Download pdf
Abstract/Description: | The present invention relates to a method of modulating an immune response to a T-cell or thymus independent antigen in a host (e.g., mammalian, including human), comprising administering to the host an effective amount of interleukin-12 (IL-12) and the T-cell independent antigen. In one embodiment, the present invention relates to a method of inducing an immune response to a TI antigen in a host (e.g., mammalian, including human), which comprises administering to the host an effective amount of interleukin-12 (IL-12) and the TI antigen. In another embodiment, the present invention relates to a method of enhancing an immune response against a TI antigen in a host, which comprises administering to the host an effective amount of IL-12 and the TI antigen. The methods of the present invention can be used, for example, to induce and or enhance a humoral immune response (IgG2a and/or IgG3 humoral immune response). |
---|---|
Subject(s): | 424/85.2 424/184.1 424/190.1 424/198.1 514/2.6 514/2.8 514/54 514/885 |
Date Issued: | 2001-10-16 |
Title: | IL-12 enhancement of immune responses to T-independent antigens. |
|
---|---|---|
Name(s): |
Medical College of Ohio, assignee Metzger, Dennis W., inventor Buchanan, Renee M., inventor |
|
Type of Resource: | text | |
Genre: | patent | |
Publisher: | United States Patent and Trademark Office | |
Other Date: | Date Filed: 1998-03-05 | |
Date Issued: | 2001-10-16 | |
Physical Form: | application/pdf | |
Extent: | 22 p. | |
Abstract/Description: | The present invention relates to a method of modulating an immune response to a T-cell or thymus independent antigen in a host (e.g., mammalian, including human), comprising administering to the host an effective amount of interleukin-12 (IL-12) and the T-cell independent antigen. In one embodiment, the present invention relates to a method of inducing an immune response to a TI antigen in a host (e.g., mammalian, including human), which comprises administering to the host an effective amount of interleukin-12 (IL-12) and the TI antigen. In another embodiment, the present invention relates to a method of enhancing an immune response against a TI antigen in a host, which comprises administering to the host an effective amount of IL-12 and the TI antigen. The methods of the present invention can be used, for example, to induce and or enhance a humoral immune response (IgG2a and/or IgG3 humoral immune response). | |
Identifier(s): |
utpatents-US6303114 (IID) Patent No.: US6303114 (patno) Appl. No.: 09/035594 (appno) |
|
Subject(s): |
424/85.2 424/184.1 424/190.1 424/198.1 514/2.6 514/2.8 514/54 514/885 |
|
Held by: | United States Patent and Trademark Office (USPTO) Public Search Facility | |
Location: | University of Toledo Digital Repository | |
Rights Statement: | No Copyright - United States | |
In Collections: |